Table 1

Study characteristics—prospectively enrolled cohorts

StudySettingSiteDesignPatients with IBD (n)IBD typeSpA criteriaSpA evaluationRheum input
Al-Jarallah et al 201233ClinicSCCS125CD/UCExam—otherNo
Al-Jarallah et al 201334ClinicSCCS130CD/UCExam—otherNo
Bandinelli et al 201124ClinicSCCS121CD/UCExam—rheumYes
Bandinelli et al 201435ClinicSCLong81CD/UCmNYExam—rheumYes
Bandyopadhyay et al 201536ClinicSCCS120CD/UCASAS (A)Exam—rheumYes
Barreiro-de Acosta et al 200737ClinicSCCS173CDExam—rheumYes
Bertolini et al 202038ClinicMCCS148CD/UCASAS (A/P)Exam—rheumYes
Beslek et al 200939ClinicSCCS122CD/UCmNY, ESSGExam—rheumYes
Christodoulou et al 200240ClinicSCCS256CD/UCSelf-report, chartNo
D’Inca et al 200941ClinicMCLong651CD/UCESSG, mNYExam—rheumYes
De Vlam et al 200042ClinicSCCS103CD/UCESSG, mNYExam—rheumYes
Ditisheim 201543PopMCCS2401CD/UCASAS (P)Self-reportYes
Dmowska-Chalaba et al 201544ClinicSCCS51CD/UCASAS (A/P)Exam—otherYes
Duricova et al 201745PopMCCS628UCExam—otherNo
Fatemi et al 201646ClinicSCCS273CD/UCmNYExam—rheumYes
Gotler et al 201547ClinicSCCS286CD/UCASAS (A)Self-report, chartYes
Hammoudeh et al 201848ClinicSCCS127CD/UCASAS (A/P)Exam—rheumYes
Hiller et al 201949PopMCLong3298CD/UCExam—otherYes
Isene et al 201550PopMCLong1145CD/UCExam—otherYes
Kamo 201551ClinicSCCS137CD/UCSelf-reportNo
Karmiris et al 201652ClinicMCCS1860CD/UCExam—rheumYes
Lakatos et al 200353ClinicSCLong873CD/UCExam—rheumYes
Lanna et al 200854ClinicSCCS130CD/UCmNYExam—rheumYes
Luchetti et al 201955ClinicSCLong262CD/UCASAS (A/P)Exam—rheumYes
Mocelin et al 201556ClinicSCCS100CDASAS (A/P)ChartYes
Orchard et al 200957ClinicSCCS44CDmNY*Exam—otherNo
Ossum et al 2018 (A)13PopMCCS470CD/UCASAS (A), mNYSelf-report†Yes
Ossum et al 2018 (P)14PopMCCS470CD/UCASAS (P)Self-report†Yes
Palm et al 200115PopMCCS521CD/UCmNYExam—rheumYes
Palm et al 200216PopMCCS406CD/UCmNY, ESSGExam—rheumYes
Peeters, 200858ClinicMCCS251CDmNYChartYes
Picchianti-Diamanti et al 202059ClinicMCCS347CD/UCASAS (A/P)Exam—rheumYes
Pokharna et al 200460ClinicSCCS46UCmNYExam—otherNo
Queiro et al 200061ClinicSCLong62CD/UCAmor, ESSG, mNYExam—otherYes
Ricart et al 200462ClinicSCCS243CD/UCSelf-reportNo
Rovisco et al 201663ClinicSCCS76CD/UCASAS (A/P)Exam—rheumYes
Sahli et al 201864ClinicSCCS64CD/UCASAS (A), AmorExam—rheumYes
Salvarani et al 200165ClinicMCCS160CD/UCmNY, ESSGExam—rheumYes
Steer et al 200366ClinicSCCS134CDmNYExam—otherYes
Stolwijk et al 201367ClinicSCCS350CD/UCSelf-report, chartYes
Subramaniam et al 201568ClinicSCCS140CD/UCASAS (A/P)Self-report, chartYes
Turkcapar et al 200669ClinicSCCS162CD/UCmNY, ESSGExam—rheumYes
Van Erp et al 201670ClinicSCLong255CD/UCASAS (A/P), Amor, ESSG, mNYExam—otherYes
Vavricka et al 2011PopMCCS950CD/UCPhysician surveyNo
Yuksel et al 201171ClinicSCCS357CD/UCExam—rheumYes
  • *Adapted for MRI.

  • †Used rheumatologist physical examination from 5-year follow-up study.

  • A, axial; ASAS, Assessment of Spondyloarthritis International Society; CD, Crohn’s disease; CS, cross-sectional; ESSG, European Spondyloarthropathy Study Group; IBD, inflammatory bowel disease; Long, longitudinal; MC, multicentre; mNY, modified New York criteria; P, peripheral; Pop, population; Rheum, rheumatologist; SC, single centre; SpA, spondyloarthritis; UC, ulcerative colitis.